Your browser doesn't support javascript.
loading
Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma.
Tian, Xiao-Peng; Zhang, Yu-Chen; Lin, Ning-Jing; Wang, Liang; Li, Zhi-Hua; Guo, Han-Guo; Ma, Shu-Yun; An, Ming-Jie; Yang, Jing; Hong, Yu-Heng; Wang, Xian-Huo; Zhou, Hui; Li, Ya-Jun; Rao, Hui-Lan; Li, Mei; Hu, Shao-Xuan; Lin, Tong-Yu; Li, Zhi-Ming; Huang, He; Liang, Yang; Xia, Zhong-Jun; Lv, Yue; Liu, Yu-Ying; Duan, Zhao-Hui; Chen, Qing-Yu; Wang, Jin-Ni; Cai, Jun; Xie, Ying; Ong, Choon-Kiat; Liu, Fang; Liu, Yan-Yan; Yan, Zheng; Huang, Liang; Tao, Rong; Li, Wen-Yu; Huang, Hui-Qiang; Cai, Qing-Qing.
Afiliação
  • Tian XP; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • Zhang YC; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • Lin NJ; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, P.R. China.
  • Wang L; Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, P.R. China.
  • Li ZH; Department of Oncology, Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, P. R. China.
  • Guo HG; Division of Lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, P.R. China.
  • Ma SY; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • An MJ; Department of Urology, Sun Yat-sen Memorial Hospital, Guangzhou, P.R. China.
  • Yang J; Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, P.R. China.
  • Hong YH; Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P.R. China.
  • Wang XH; Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P.R. China.
  • Zhou H; Department of Lymphoma and Hematology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, P.R. China.
  • Li YJ; Department of Lymphoma and Hematology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, P.R. China.
  • Rao HL; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • Li M; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • Hu SX; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, P.R. China.
  • Lin TY; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • Li ZM; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • Huang H; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • Liang Y; Department of Hematology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • Xia ZJ; Department of Hematology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • Lv Y; Department of Hematology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • Liu YY; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • Duan ZH; Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Guangzhou, P.R. China.
  • Chen QY; Department of Medical Examination Center, Sun Yat-sen Memorial Hospital, Guangzhou, P.R. China.
  • Wang JN; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • Cai J; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.
  • Xie Y; Guangdong Provincial Academy of Chinese Medical Sciences, State Key Laboratory of Dampness Syndrome of Chinese Medicine, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, P.R. China.
  • Ong CK; Lymphoma Genomic Translational Research Laboratory, Division of Cellular and Molecular Research, National Cancer Centre Singapore, 11 Hospital Drive, 169610 Singapore, Singapore.
  • Liu F; Department of Pathology, The First People's Hospital of Foshan, Foshan, P.R. China.
  • Liu YY; Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, 127 Dongming Road, Zhengzhou 450008, P.R. China.
  • Yan Z; Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, 127 Dongming Road, Zhengzhou 450008, P.R. China.
  • Huang L; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.
  • Tao R; Department of Lymphoma, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China. Electronic address: rtao@shca.org.cn.
  • Li WY; Department of Urology, Sun Yat-sen Memorial Hospital, Guangzhou, P.R. China. Electronic address: lwy80411@163.com.
  • Huang HQ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China. Electronic address: huanghq@sysucc.org.cn.
  • Cai QQ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China. Electronic address: caiqq@sysucc.org.cn.
Cell Rep Med ; 4(2): 100859, 2023 02 21.
Article em En | MEDLINE | ID: mdl-36812892
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Extranodal de Células T-NK / DNA Tumoral Circulante Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cell Rep Med Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Extranodal de Células T-NK / DNA Tumoral Circulante Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cell Rep Med Ano de publicação: 2023 Tipo de documento: Article